Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mild asthma reliever strategy trial comparing as-needed budesonide/formoterol, as-needed salbutamol, and maintenance budesonide
ACTRN12615000999538Phase 3Completed
- Sponsor
- Medical Research Institute of New Zealand
- Start
- Mar 2016
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 4
01
Overview
Phase 3, randomised, open-label trial in asthma comparing As-needed budesonide/formoterol, As-needed salbutamol and Maintenance budesonide plus as-needed salbutamol (3 arms). Primary endpoint: Asthma exacerbation rate. Started Mar 2016; status: completed.
02
Drugs
budesonide + formoterolsalbutamolbudesonide
03
Conditions
asthma
Beyond the preview
Go deeper on ACTRN12615000999538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000999538.